Sorbent Therapeutics

Sorbent expands financing by $36 million

Thursday, June 30, 2011

Sorbent Therapeutics, a biopharmaceutical company, has expanded its Series B financing from September 2010 by $36 million. This brings the total proceeds of the second financing round to $53 million. Investor Novartis Venture Funds led the financing, joining existing investors Sofinnova Ventures, ARCH Venture Partners, CMEA Capital and AgeChem.

[Read More]